"You decide and we provide."
Cart 0

U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant




reutersCOMPANYNEWS companyNews

WASHINGTON, April 14 (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the companies said on Friday.




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published